Buscar resultados de ensayos clínicos
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - 25 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) Condición: T-ALL, T-NHL (Lymphoblastic) Fecha: 2008-05-16 Intervenciones: Drug: Nelarabine 1500 mg/m² i.v., duration 2 hrs, day 1, 3, 5 |
Completed |
Nombre del estudio: Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden. Condición: T-cell Acute Lymphoblastic Leukemia Fecha: 2013-09-07 |
Recruiting |
Nombre del estudio: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Condición:
|
Terminated |
Nombre del estudio: Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL Condición:
|
Active, not recruiting |
Nombre del estudio: Evaluation and Treatment of Tall Statured Girls Condición: Constitutional Tall Stature Fecha: 2015-12-13 Intervenciones: Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner. |
Recruiting |
Nombre del estudio: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma Condición:
|
Active, not recruiting |
Nombre del estudio: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Condición:
|
Recruiting |
Nombre del estudio: Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia Condición: T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia Fecha: 2016-12-19 Intervenciones:
|
Recruiting |
Nombre del estudio: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma Condición:
|
Active, not recruiting |
Nombre del estudio: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma Condición:
|